Insider · CIK 0001827672
Bobak R. Azamian
Files at TARS (Tarsus Pharmaceuticals, Inc.). First filing Mar 20, 2025, latest Sep 9, 2026.
Bobak R. Azamian files SEC Form 4 as CEO, president, chair and director at TARS (Tarsus Pharmaceuticals, Inc.). Since Mar 20, 2025, Bobak R. Azamian has reported 0 open-market buys worth $0 and 9 open-market sells worth $7.3M, the latest filed on Sep 9, 2026.
A track record needs three past buys with six months of prices behind them; Bobak R. Azamian has 0, so none is measured yet.
The newest scored trade: sold $906k of TARS on Sep 4, 2026, filed Sep 9, 2026, scored 44 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $5.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TARS: Tarsus Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Tarsus Pharmaceuticals, Inc. | $906k 10,000 shares | -1% | - | |
| 42Moderate | Tarsus Pharmaceuticals, Inc. | $801k 10,000 shares | -1% | - | |
| 40Moderate | Tarsus Pharmaceuticals, Inc. | $615k 10,000 shares | -1% | +61% from low-24% from high | |
| 85Strong | Tarsus Pharmaceuticals, Inc. | $2.4M 34,603 shares | -51% | +80% from low-15% from high | |
| 38Weak | Tarsus Pharmaceuticals, Inc. | $495k 6,000 shares | -1% | +113% from low0% from high | |
| 20Weak | Tarsus Pharmaceuticals, Inc. | $332k 6,000 shares | -1% | +71% from low-6% from high | |
| 19Weak | Tarsus Pharmaceuticals, Inc. | $300k 6,000 shares | -1% | +61% from low-12% from high | |
| 27Weak | Tarsus Pharmaceuticals, Inc. | $300k 6,000 shares | -1% | - | |
| 68Notable | Tarsus Pharmaceuticals, Inc. | $1.2M 24,216 shares | -31% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 4, 2026 | TARS TARSUS PHARMACEUTICALS INC | 10,000 0.02% of outstanding | $906k | Sep 4, 2026 | $1.4M |
| Sep 2, 2026 | TARS TARSUS PHARMACEUTICALS INC | 10,000 0.02% of outstanding | $801k | Sep 2, 2026 | $615k |
| Jun 17, 2026 | TARS TARSUS PHARMACEUTICALS INC | 10,000 0.02% of outstanding | $615k | Jun 17, 2026 | none |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | 11,964 0.03% of outstanding | $802k | Mar 19, 2026 | $1.6M |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | 11,667 0.03% of outstanding | $802k | Mar 18, 2026 | $762k |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | 10,972 0.03% of outstanding | $762k | Mar 17, 2026 | none |
| Mar 16, 2026 | TARS TARSUS PHARMACEUTICALSINC | 12,500 0.03% of outstanding | $860k | Mar 16, 2026 | $1.9M |
| Dec 29, 2025 | TARS TARSUS PHARMACEUTICALS INC | 6,000 0.01% of outstanding | $495k | Dec 24, 2025 | none |
| Sep 24, 2025 | TARS TARSUS PHARMACEUTICALS INC | 6,000 0.01% of outstanding | $332k | Sep 24, 2025 | $300k |
| Aug 11, 2025 | TARS Tarsus Pharmaceuticals, Inc. | 6,000 0.01% of outstanding | $300k | Aug 11, 2025 | none |
| Mar 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | 6,000 0.02% of outstanding | $300k | Mar 24, 2025 | $428k |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | 8,534 0.02% of outstanding | $428k | Mar 20, 2025 | $735k |
| Mar 19, 2025 | TARS Tarsus Pharmaceuticals, Inc. | 8,551 0.02% of outstanding | $405k | Mar 19, 2025 | $330k |
| Mar 18, 2025 | TARS Tarsus Pharmaceuticals, Inc. | 7,131 0.02% of outstanding | $330k | Mar 18, 2025 | none |
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -7,100 | $90.27 | $641k | 830,891 | 34 d ago |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -2,900 | $91.27 | $265k | 827,991 | 34 d ago |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -10,000 | $80.06 | $801k | 837,991 | 40 d ago |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -4,582 | $61.24 | $281k | 853,409 | Jun 22, 2026 |
| Jun 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -5,418 | $61.81 | $335k | 847,991 | Jun 22, 2026 |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -10,972 | $69.42 | $762k | 57,052 | Mar 19, 2026 |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -11,667 | $68.71 | $802k | 45,385 | Mar 19, 2026 |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -11,964 | $67.00 | $802k | 33,421 | Mar 19, 2026 |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +66,274 | - | - | 68,024 | Mar 17, 2026 |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,300 | $0.00 | $0 | 0 | Mar 17, 2026 |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,975 | $0.00 | $0 | 16,975 | Mar 17, 2026 |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -23,121 | $0.00 | $0 | 46,243 | Mar 17, 2026 |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,878 | $0.00 | $0 | 44,634 | Mar 17, 2026 |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +96,723 | $0.00 | $0 | 96,723 | Mar 9, 2026 |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +60,776 | $0.00 | $0 | 60,776 | Mar 9, 2026 |
| Dec 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -5,443 | $82.41 | $449k | 858,548 | Dec 30, 2025 |
| Dec 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -557 | $83.54 | $47k | 857,991 | Dec 30, 2025 |
| Dec 4, 2025 | TARS Tarsus Pharmaceuticals, Inc. | GGift Common Stock | -51,885 | $0.00 | $0 | 1,750 | Dec 8, 2025 |
| Sep 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -6,000 | $55.37 | $332k | 812,106 | Sep 26, 2025 |
| Aug 11, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -6,000 | $50.00 | $300k | 818,106 | Aug 13, 2025 |
| Mar 24, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By the Bobak Azamian Living Trust established April 16, 201810b5-1 | -6,000 | $50.00 | $300k | 824,106 | Mar 26, 2025 |
| Mar 18, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,131 | $46.29 | $330k | 70,720 | Mar 20, 2025 |
| Mar 19, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -8,551 | $47.40 | $405k | 62,169 | Mar 20, 2025 |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -8,534 | $50.11 | $428k | 53,635 | Mar 20, 2025 |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +51,395 | - | - | 77,851 | Mar 18, 2025 |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,299 | $0.00 | $0 | 11,300 | Mar 18, 2025 |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,975 | $0.00 | $0 | 33,950 | Mar 18, 2025 |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -23,121 | $0.00 | $0 | 69,364 | Mar 18, 2025 |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +90,736 | $0.00 | $0 | 90,736 | Mar 7, 2025 |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +59,512 | $0.00 | $0 | 59,512 | Mar 7, 2025 |
Questions about Bobak R. Azamian
Answered from the filings on this page, as of the latest one.
Is Bobak R. Azamian buying or selling?
In the last 12 months Bobak R. Azamian reported 0 open-market buys worth $0 and 5 open-market sells worth $5.2M on SEC Form 4; the latest was sold $906k of TARS on Sep 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Bobak R. Azamian's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bobak R. Azamian has 0.
Where does Bobak R. Azamian file Form 4?
Bobak R. Azamian has filed Form 4 at TARS (Tarsus Pharmaceuticals, Inc.) as President/CEO and Board Chair. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.